Your browser doesn't support javascript.
loading
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature.
García-Cadenas, Irene; Redondo, Sara; Esquirol, Albert; Portos, J M; Novelli, Silvana; Saavedra, Silvana; Moreno, Carol; Garrido, Ana; Oñate, Guadalupe; López, Jordi; Caballero, Ana-Carolina; Miqueleiz, Sara; Arguello-Tomas, Miguel; Briones, Javier; Sierra, Jorge; Martino, Rodrigo.
Affiliation
  • García-Cadenas I; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Redondo S; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Esquirol A; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Portos JM; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Novelli S; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Saavedra S; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Moreno C; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Garrido A; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Oñate G; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • López J; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Caballero AC; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Miqueleiz S; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Arguello-Tomas M; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Briones J; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Sierra J; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
  • Martino R; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and José Carreras Leukemia Research Institutes, Departamento de Medicina, Universidad Autónoma de Barcelona. Barcelona, Spain.
Transplant Cell Ther ; 29(7): 473.e1-473.e6, 2023 07.
Article in En | MEDLINE | ID: mdl-37086849
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Primary Myelofibrosis / Graft vs Host Disease Type of study: Etiology_studies / Guideline Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Primary Myelofibrosis / Graft vs Host Disease Type of study: Etiology_studies / Guideline Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2023 Type: Article Affiliation country: Spain